CompletedNCT01623713
What is this study about?Researchers compared iloperidone and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In BeijingSchizophreniaMedication studyAges 18–65
- Countries
- China
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
TerminatedNCT00658645
What is this study about?Researchers are comparing Bifeprunox, placebo and Quetiapine to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including RadnevoSchizophreniaMedication studyAges 18–65
- Countries
- Bulgaria, China, Greece, + 5 others
- Sponsor
- H. Lundbeck A/S
CompletedNCT01393613
What is this study about?Researchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
- Countries
- United States, Colombia, Croatia, + 5 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT02477670
What is this study about?This study evaluated the safety and effectiveness of AVP-786 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT01668797
What is this study about?Researchers compared Brexpiprazole and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 18–65
- Countries
- United States, Colombia, Malaysia, + 4 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)